Twine Health raised $6.75 million in series A funding for its health coaching platform. The money was provided by Khosla Ventures, Provenance Venture Forum, and Tower Capital Partners, as well as industry veterans Andy Palmer, James Pallotta and Henri Termeer.
Twine has shown that its platform can allow practices to achieve hypertension and diabetes control rates greater than 90%.Prior to its commercial launch, Twine demonstrated effectiveness in hypertension and diabetes care. A clinical trial with Massachusetts General Hospital showed an average 26mmHg drop in blood pressure in three months, compared to an average drop under traditional care of 6mmHg in one year. A trial with Joslin Diabetes Center showed an average 3.2 drop in HbA1C, compared to an average drop in a traditional setting of 1.0 in one year. Also, the company has shown that its platform can allow practices to achieve hypertension and diabetes control rates greater than 90%. Twine and its clinical partners expect to see similar results across all major chronic diseases.
“Our clinical partners have bought into true health coaching. To us, that’s having care teams who work with patients to set goals and provide continuous support to reach those goals,” said Twine CEO John Moore. “The key to successful health coaching is an empathetic human touch from someone who understands the psychology of health behavior change. Instead of trying to replicate or replace that human touch, we build technology that allows health coaches to scale their reach to superhuman proportions and empowers patients to build maximal self-efficacy.”